Published in Br J Haematol on December 01, 1983
Organization of immunological memory by bone marrow stroma. Nat Rev Immunol (2010) 3.57
Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J Clin Invest (1989) 2.23
Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endopeptidase 24.11 ("enkephalinase"): direct evidence by cDNA transfection analysis. Proc Natl Acad Sci U S A (1989) 1.67
Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein. Proc Natl Acad Sci U S A (1988) 1.41
Expression of the common acute lymphoblastic leukemia antigen (CD10) in mesenchymal tumors. Am J Pathol (1989) 1.03
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 37.55
Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy (2005) 5.92
Electric field-mediated DNA transfer: transient and stable gene expression in human and mouse lymphoid cells. Mol Cell Biol (1986) 2.51
Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant (2007) 2.47
Isolated chloroma: the effect of early antileukemic therapy. Ann Intern Med (1995) 2.29
Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood (1986) 2.27
The influence of antecedent reinforcement and divergent modeling cues on patterns of self-reward. J Pers Soc Psychol (1966) 2.26
Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med (1989) 2.05
Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration. Proc Natl Acad Sci U S A (1985) 1.94
Expression of the gene defect in X-linked agammaglobulinemia. N Engl J Med (1986) 1.80
High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. Blood (1998) 1.72
Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation. Blood (1991) 1.63
Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention. Proc Natl Acad Sci U S A (2000) 1.53
Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med (1979) 1.44
Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA. Cancer Res (1993) 1.44
Thoracic radiation therapy before autologous bone marrow transplantation in relapsed or refractory Hodgkin's disease. PMH Lymphoma Group, and the Toronto Autologous BMT Group. Eur J Cancer (1999) 1.44
High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an autologous blood and marrow transplant registry report. Ann Intern Med (2000) 1.42
Biology of bone marrow stroma. Ann N Y Acad Sci (1995) 1.41
Acute transient parotitis after high dose etoposide and autologous bone marrow transplantation. Bone Marrow Transplant (1990) 1.40
An evaluation of outpatient bone marrow harvesting. J Clin Oncol (1989) 1.39
Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. J Clin Oncol (2000) 1.36
Temporal analysis of the relationship of smoking behavior and urges to mood states in men versus women. Nicotine Tob Res (2001) 1.35
Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man. Nature (1982) 1.35
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol (2001) 1.34
Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia. N Engl J Med (1987) 1.32
Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid. Proc Natl Acad Sci U S A (1994) 1.31
The L4F3 antigen is expressed by unipotent and multipotent colony-forming cells but not by their precursors. Blood (1986) 1.29
Transplanted adult spinal cord-derived neural stem/progenitor cells promote early functional recovery after rat spinal cord injury. Neuroscience (2008) 1.28
Acute nonlymphocytic leukemia: heterogeneity of stem cell origin. Blood (1981) 1.26
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer. Ann Oncol (2011) 1.23
Cloning and expression of two human lysophosphatidic acid acyltransferase cDNAs that enhance cytokine-induced signaling responses in cells. DNA Cell Biol (1997) 1.23
Stable expression of selectable genes introduced into human hematopoietic stem cells by electric field-mediated DNA transfer. Proc Natl Acad Sci U S A (1986) 1.23
Toxicity and efficacy of human leukocyte interferon for treatment of cytomegalovirus pneumonia after marrow transplantation. J Infect Dis (1980) 1.22
Selective effects of cyclosporin A on colony-forming lymphoid and myeloid cells in man. Nature (1979) 1.20
A social ecology of hyperactive boys: medication effects in structured classroom environments. J Appl Behav Anal (1979) 1.17
Effect of granulocyte-macrophage colony-stimulating factor and interleukin-3 on interleukin-8 production by human neutrophils and monocytes. Blood (1993) 1.17
Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer. Br J Cancer (2008) 1.14
A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer. Ann Oncol (2013) 1.11
Humoral and cellular immune mechanisms of neutropenia in patients with Felty's syndrome. Clin Exp Immunol (1980) 1.11
Treatment of cytomegaloviral pneumonia with high-dose acyclovir and human leukocyte interferon. J Infect Dis (1983) 1.11
Effect of 5-azacytidine on gene expression in marrow stromal cells. Mol Cell Biol (1989) 1.10
Chronic myelocytic leukemia (CML): failure to detect residual normal committed stem cells in vitro. Blood (1979) 1.09
Unicellular or multicellular origin of human granulocyte-macrophage colonies in vitro. Blood (1979) 1.09
Potential role for phosphatidic acid in mediating the inflammatory responses to TNF alpha and IL-1 beta. Circ Shock (1994) 1.05
Steroids and hematopoiesis. I. The effect of steroids on in vitro erythroid colony growth: structure/activity relationships. J Cell Physiol (1976) 1.05
Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med (1991) 1.05
Coculture studies of 16 untransfused patients with aplastic anemia. Blood (1979) 1.04
Intrathecal transplantation of stem cells by lumbar puncture for thoracic spinal cord injury in the rat. Spinal Cord (2011) 1.04
Electric field-mediated gene transfer: characterization of DNA transfer and patterns of integration in lymphoid cells. Nucleic Acids Res (1988) 1.04
CT-1501R selectively inhibits induced inflammatory monokines in human whole blood ex vivo. Shock (1994) 1.03
Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol (1999) 1.02
Simian virus 40-transformed adherent cells from human long-term marrow cultures: cloned cell lines produce cells with stromal and hematopoietic characteristics. Blood (1987) 1.01
Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia. Blood (1992) 1.01
Location and distribution of difucoganglioside (VI3NeuAcV3III3Fuc2nLc6) in normal and tumor tissues defined by its monoclonal antibody FH6. Cancer Res (1985) 1.01
Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission. Blood (2000) 1.01
Serum reactivity to human T-cell leukaemia/lymphoma virus type I proteins in patients with large granular lymphocytic leukaemia. Lancet (1987) 1.01
Pyramid therapy in a hospital for the retarded: methods, program evaluation, and long-term effects. Am J Ment Defic (1971) 1.00
Chronic stress and illness in children: the role of allostatic load. Psychosom Med (1998) 1.00
Prosocial behavior in hyperactive boys: effects of stimulant medication and comparison with normal boys. J Abnorm Child Psychol (1992) 1.00
Single or multicellular origin of human T lymphocyte colonies in vitro: modification by 12-o-tetradecanoylphorbol 13-acetate (TPA). J Immunol (1981) 0.99
The CD34 antigen: structure, biology, and potential clinical applications. J Hematother (1992) 0.98
Polycythemia vera. Increased expression of normal committed granulocytic stem cells in vitro after exposure of marrow to tritiated thymidine. J Clin Invest (1979) 0.98
Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol (1994) 0.98
A clonal complete remission in a patient with acute nonlymphocytic leukemia originating in a multipotent stem cell. N Engl J Med (1984) 0.98
Does stimulant medication improve the peer status of hyperactive children? J Consult Clin Psychol (1989) 0.98
E2F1 and p53 are dispensable, whereas p21(Waf1/Cip1) cooperates with Rb to restrict endoreduplication and apoptosis during skeletal myogenesis. Dev Biol (2000) 0.97
Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation. Blood (1990) 0.97
Radiation-associated pneumonitis following autologous stem cell transplantation: predictive factors, disease characteristics and treatment outcomes. Bone Marrow Transplant (2001) 0.96
Creating therapeutic pyramids using mentally retarded patients. Am J Ment Defic (1969) 0.96
The generation of human long-term marrow cultures from marrow depleted of Ia (HLA-DR) positive cells. Blood (1984) 0.96
CGA-7 and HHF, two monoclonal antibodies that recognize muscle actin and react with adherent cells in human long-term bone marrow cultures. Blood (1985) 0.96
Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation. Bone Marrow Transplant (1995) 0.96
Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of age. Bone Marrow Transplant (2003) 0.95
Worldly and workday worries: contemporary concerns of children and young adolescents. J Abnorm Child Psychol (1995) 0.95
Ovarian function after autologous bone marrow transplantation. J Clin Oncol (1998) 0.94
Hematopoietic stem cells engraft in untreated transplant recipients. Exp Hematol (1993) 0.94
Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin's lymphoma (NHL): results of a provincial strategy. Ontario BMT Network, Canada. Bone Marrow Transplant (2000) 0.94
Malakoplakia: evidence for an acquired disease secondary to immunosuppression. Transplantation (1981) 0.94
Phosphatidic acid signaling mediates lung cytokine expression and lung inflammatory injury after hemorrhage in mice. J Exp Med (1995) 0.94
Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma. Br J Haematol (2001) 0.93
An increase in serum C18 unsaturated free fatty acids as a predictor of the development of acute respiratory distress syndrome. Crit Care Med (1996) 0.93
Expression of lysophosphatidic acid acyltransferase beta (LPAAT-beta) in ovarian carcinoma: correlation with tumour grading and prognosis. Br J Cancer (2005) 0.92
Polycythemia vera. Further in vitro studies of hematopoietic regulation. J Clin Invest (1980) 0.92
Treatment of aplastic anemia by bone marrow transplantation in identical twins. Blood (1980) 0.92
Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research. Bone Marrow Transplant (2007) 0.92
Nonhematopoietic mesenchymal stem cells: what are they? Cytotherapy (2000) 0.92
Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressed. J Clin Invest (1987) 0.91
Marrow transplantation from donors other than HLA-identical siblings. Transplantation (1979) 0.91
Steroids and hematopoiesis. II. The effect of steroids on in vitro erythroid colony growth: evidence for different target cells for different classes of steroids. J Cell Physiol (1976) 0.91
Restoration of nonclonal hematopoiesis in chronic myelogenous leukemia (CML) following a chemotherapy-induced loss of the Ph1 chromosome. Blood (1980) 0.91